Evidence map›Paper›PMID 40637519›Full record

ArticleJournal of the American Chemical Society2025

Multistep 11-

Matthias Broser, Spyridon Kaziannis, Ivo H M van Stokkum, Atripan Mukherjee, Jakub Dostal, Wayne Busse, Arno Munhoven, Cesar Bernardo, Peter Hegemann, Miroslav Kloz and 1 more

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Retina-Inspired Bi-Based Terahertz Photonic Neuromorphic Devices.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Matthias BroserInstitut für Biologie, Experimentelle Biophysik, Humboldt Universität zu Berlin, Invalidenstrasse 42, Berlin D-10115, Germany.ORCID 0000-0002-7133-4548
Spyridon KaziannisELI Beamlines Facility, The Extreme Light Infrastructure ERIC, Za Radnicí 835, Dolní Břežany 252 41, Czech Republic.
Ivo H M van StokkumDepartment of Physics and Astronomy, Vrije Universiteit Amsterdam, De Boelelaan 1100, Amsterdam 1081 HV, the Netherlands.ORCID 0000-0002-6143-2021
Atripan MukherjeeELI Beamlines Facility, The Extreme Light Infrastructure ERIC, Za Radnicí 835, Dolní Břežany 252 41, Czech Republic.
Jakub DostalELI Beamlines Facility, The Extreme Light Infrastructure ERIC, Za Radnicí 835, Dolní Břežany 252 41, Czech Republic.
Wayne BusseInstitut für Biologie, Experimentelle Biophysik, Humboldt Universität zu Berlin, Invalidenstrasse 42, Berlin D-10115, Germany.
Arno MunhovenInstitut für Biologie, Experimentelle Biophysik, Humboldt Universität zu Berlin, Invalidenstrasse 42, Berlin D-10115, Germany.
Cesar BernardoELI Beamlines Facility, The Extreme Light Infrastructure ERIC, Za Radnicí 835, Dolní Břežany 252 41, Czech Republic.
Peter HegemannInstitut für Biologie, Experimentelle Biophysik, Humboldt Universität zu Berlin, Invalidenstrasse 42, Berlin D-10115, Germany.ORCID 0000-0003-3589-6452
Miroslav KlozELI Beamlines Facility, The Extreme Light Infrastructure ERIC, Za Radnicí 835, Dolní Břežany 252 41, Czech Republic.
John T M KennisDepartment of Physics and Astronomy, Vrije Universiteit Amsterdam, De Boelelaan 1100, Amsterdam 1081 HV, the Netherlands.ORCID 0000-0002-3563-2353

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rhodopsins constitute a broad class of retinal-binding photoreceptors. Microbial rhodopsins are canonically activated through an all-

Indexed as

RetinaldehydeRhodopsins, MicrobialIsomerismPhotochemical ProcessesStereoisomerismRetinaldehydeRhodopsins, Microbial

Identifiers

PMID40637519
PMCPMC12291454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.